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Hepatitis E virus (HEV) is a ssRNA positive-strand 
virus, a member of the Hepevirus genus, Hepeviridae 
family and consists of 4 major genotypes (1, 2, 3 and 4). 
Genotypes 1 and 2 of HEV have been found only in 
humans and they are responsible for epidemics in 
endemic regions (HEV 1 in North America and Asia, 
HEV 2 in West Africa and Mexico). The transmission 
is primarily via the faecal-oral route through drinking 
water or food contaminated with human excreta. In 
developed countries those two genotypes cause travel 
associated infections, in Europe cases caused by HEV 1 
are predominant. Genotypes 3 and 4 of HEV have been 
found in humans and animals (pigs, wild boars, shell-
fish and other), and are responsible for worldwide auto-
chthonous infections. Zoonotic transmission to humans 
is the most important for HEV genotypes 3 and 4. Con-
sumption of raw or undercooked wild-boar meat, offal 
or beef is significantly associated with autochthonous 
HEV infection. HEV infections caused by blood trans-
fusions, mother-to-child, person-to-person, and sexual 
intercourses were also documented but uncommonly 
noted. In Europe, there is mostly genotype 3 in humans, 
but a few cases of HEV 4 were described (Wichmann 
et al., 2008; Lee et al., 2015; Pérez-Gracia et al., 2015). 
HEV-infected persons exhibit a wide clinical spectrum, 
ranging from asymptomatic infection through acute 
icteric hepatitis to fulminant hepatitis. Acute hepati-
tis E usually manifests with icterus, malaise, anorexia, 
fever, hepatomegaly, and occasionally pruritus. Certain 
population sub-groups are at a higher risk of severe 
disease following HEV infection. These include preg-
nant women, persons with pre-existing liver disease and 
persons with immuno suppression (WHO, 2014).
Contact exposure to infected animals leads to an 
elevated risk of HEV transmission in humans. Studies 
have shown that occupational groups e.g. swine breed-
ers (Forgách et al., 2007), slaughterers (Krumbholz et al., 
2012), veterinarians who come into close contact with 
pigs (Bouwknegt et al., 2008) run the risk of being 
infected with HEV. Swine workers in Spain were found 
to be 5.4 times more likely to be positive for anti-HEV 
IgG than those not exposed to swine (Galiana et al., 
2008). Contact with swine is the most widely recog-
nized route for occupational exposure to HEV; how-
ever, the multitude of novel strains of HEV in wildlife 
and other domestic animal species suggest additional 
mechanisms of transmission (Yugo and Meng, 2013). 
The aim of the study was the analysis of the occurrence 
of specific antibodies against HEV among hunters and 
foresters who are at risk to be exposed.
The study group consisted of 210 hunters aged 23–80 
(54, SD 11.61): 208 men (99.05%) and 2 women (0.95%) 
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The aim of the study was the analysis of the occurrence of specific antibodies against HEV among hunters and foresters who are at risk to 
be exposed. The study group consisted of 210 hunters (23–80 years old) and 60 foresters (22–64 years old). Anti-HEV IgG were present 
in 3.81% of the samples of the hunters and in 5% of the samples of the foresters. The statistical analysis shows no significant differences in 
the results anti-HEV IgG between the groups of hunters and foresters (p = 0.5278). Significantly higher anti-HEV IgG titers were found 
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and 60 male foresters, aged 22–64 (45.63, SD 11.81). 
The selection of the groups was purposeful because 
hunters and foresters have a diverse activity by being 
in the forest environment. Blood samples were col-
lected in Lubelskie voivodship from 2014 to 2015. 
The groups of hunters and foresters were divided into 
three age groups: ≤ 35 years old, 36–55 years, > 55 
years. The Bioethical Committee of Medical Uni-
versity of Lublin authorized the project (permission 
No. KE-0254/177/2014).
Serological analysis. The presence of anti-HEV IgG 
was detected by ELISA (Anti-Hepatitis E virus (HEV) 
ELISA IgG, Euroimmun). Microtiter wells were coated 
with mixed recombinant antigens of Hepatitis E virus 
genotypes 1 and 3. The results above or equal 2.2 rela-
tive units/ml (RU/ml) were considered as positive, 
below 1.6 RU/ml as negative, whereas borderline results 
were ≥ 1.60 and < 2.2 RU/ml. The test was carried out 
and the results were interpreted according to the manu-
facturer’s instructions.
The obtained data were analysed statistically using 
Statistica v. 10 software. The Chi-square test was per-
formed for nominal features in order to detect sta-
tistically significant dependence. For data expressed 
numerically nonparametric Mann-Whitney U and 
Kraskala-Wallisa test was performed. The assumptive 
level of significance was p = 0.05.
The results for anti-HEV IgG in hunters group were 
as follows: 8 positive samples (3.81%), 10 borderline 
(4.76%) and 192 negative (91.43%). Anti-HEV IgG in 
the foresters group were detected in 3 samples (5%) 
at positive level and in 1 sample (1.67%) at borderline 
level. Anti-HEV antibodies were not reported among 56 
(93.33%) foresters. The statistical analysis shows no sig-
nificant differences in the titers anti-HEV IgG between 
the groups of hunters and foresters (p = 0.5278). The 
titers of anti-HEV IgG were presented in Table I. 
Significant statistical differences (p = 0.004) in titers 
of anti-HEV IgG between the age group 36–55 (0.58, 
SD 0.71), and the age group > 55 (1.06, SD 2.94) for 
all the tested subjects were found. There were also sig-
nificant statistical differences (p = 0.0194) in IgG titers 
between the age group of ≤ 35 (1.08, SD 3.05) and the 
age group > 55 (1.06, SD 2.94) for all the tested subjects. 
Significant statistical differences (p = 0.0119) in titers 
of anti-HEV IgG between the age group 36–55 (0.59, 
SD  0.75) and the age group > 55 (0.89, SD  2.08) for 
the hunters were found.
In the study of Sadowska-Todys et al. (2015) per - 
formed in Poland among 1027 hunters (17 to 85 years 
of age), in 206 persons (25%) anti-HEV IgG were found 
by means of ELISA test (positive and borderline result). 
Anti-HEV IgM were confirmed in 3 persons. The study 
showed that the percentage of persons with anti-HEV 
IgG is the highest in the age group ≥ 70 and the differ-
ence is statistically significant comparing to other age 
groups. No relation between the percentage of sero-
positive persons and the duration of hunting activities 
was found.
In our study 210 hunters aged 23–80 were examined. 
At the beginning of the experiment we assumed that the 
forester group, without the direct contact with animals, 
would be the control group of the study. Positive results 
anti-HEV IgG were present in 3.81% of the samples 
of the hunters group and in 5% of the samples of the 
foresters. The statistical analysis in our study showed 
no significant differences in the results anti-HEV IgG 
between the groups of hunters and foresters. The 
higher titers anti-HEV IgG was in the older age groups, 
significantly higher antibody titers demonstrated in the 
age group > 55 years.
It has already been described by Carpentier et al. 
(2012) in France, which forestry workers, particularly 
woodcutters are group endangered with HEV infec-
Hunters ≤ 35 17 0.68 0.26 0.20  4.00 0.96
 36–55 99 0.59 0.30 0.20  5.57 0.75
 > 55 94 0.89*** 0.46 0.20 19.71 2.08
Foresters ≤ 35 13 1.61 0.22 0.20 16.73 4.55
 36–55 32 0.55 0.26 0.20  2.79 0.56
 > 55 15 2.13 0.47 0.20 24.00 6.07
All studied persons ≤ 35 30 1.08 0.25 0.20 16.73 3.05
 36–55 131 0.58 0.29 0.20  5.57 0.71
 > 55 109 1.06*/** 0.46 0.20 24.00 2.94
Total  270 0.83 0.35 0.20 24.00 2.19
Table I
The titers of anti-HEV IgG depending on the age of hunters and foresters
Significant differences: * p = 0.004; ** p = 0.0194; *** p = 0.0119
The titers of anti-HEV IgG (RU/ml)
Group




tion. French forestry workers (n = 593) were tested for 
anti-HEV antibodies. One hundred eighty five sub-
jects had anti-HEV antibodies (31.2%) with prevalence 
increasing steadily from 15.7% in 15–34-year-olds to 
46.2 in subjects older than 55 years of age. Among the 
135 controls with no direct contact with the forest envi-
ronment (drivers, gardeners, traders) 26 (19.2%) had 
anti-HEV antibodies with the prevalence increasing 
from 4.5% in subjects aged 15 to 34 to 39% in elders. 
In the study of Montegnaro et al. (2015) performed in 
central Italy (Latium region) HEV seroprevelance was 
noted among 25% of the examined hunters. In Italy 
several authors have demonstrated an appreciable 
frequency of HEV infection, generally in travellers 
returning from endemic areas, however autochthonous 
cases have also been documented pointing to a pos-
sible autochthonous circulation of the virus in human 
population, sustained by the presence of an animal res-
ervoir of HEV. In the study of Schielke et al. (2015) on 
126 hunters (median age 55; 94% male) 21% tested were 
positive for anti-HEV IgG antibodies. Anti-HEV preva-
lence was the highest in the age group of the 70–79 
(67%). Hepatitis  E has been observed in Germany 
since 2001. Since then, the number of recorded cases 
has been increasing steadily each year. Men between 
50–69  years of age are the most affected group with 
0.9 cases per 100,000 popu lations. Underreporting is 
expected due to asymptomatic and underdiagnosed 
infections. In forest workers, anti-HEV prevalence of 
18% in Germany was reported (Dremsek et al., 2012). 
Our study confirmed the higher exposure in older age 
groups, significantly higher anti-HEV titer demon-
strated in the age group > 55.
In the study of Bura et al. (2015) 182  patients 
(101  men and 81 women), aged 19–85 (47.2 ± 14.2; 
half of the patients were under 48), hospitalized for 
different reasons in Wielkopolska Region (infec-
tious and non-infectious liver diseases, diarrheal ill-
nesses, herpes zoster, HIV infection, meningitis and 
erysipelas) were examined. Anti-HEV were found in 
29 patients (15.9%).
In conclusion, the zoonotic risk of HEV is well 
established but seroprevelance in humans varies drasti-
cally between studies and countries. Numerous animal 
species seropositive for IgG anti-HEV, contaminated 
food, water and environment must be considered as 
potential sources of HEV infections in humans.
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